("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2025. Net sales of $ ...

Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...

(“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2025 ...

Q2 2025 Earnings Call Transcript February 6, 2025 Operator: Hello, and thank you for standing by. My name is Regina, and I ...

Barclays raised the firm’s price target on Phibro Animal Health (PAHC) to $22 from $20 and keeps an Underweight rating on the shares following ...

Growth stocks are attractive to many investors, as above-average financial growth helps these ... to analyze a company's real growth prospects. Phibro Animal Health (PAHC) is one such stock ...

("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for ...

TEANECK, N.J. (AP) — TEANECK, N.J. (AP) — Phibro Animal Health Corp. (PAHC) on Wednesday reported fiscal second-quarter net income of $3.2 million. The Teaneck, New Jersey-based company said ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...